NCT02537210View on ClinicalTrials.gov

Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative Colitis

NACompletedINTERVENTIONAL
Enrollment

177

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

September 10, 2021

Study Completion Date

September 10, 2021

Conditions
Colitis, UlcerativeAminosalicylic Acid
Interventions
DRUG

Mesalazine

Patients will be prescribed Asacol 2g daily for 12 months

DRUG

Placebo oral capsule

Patients will be prescribed placebo 5 capsules daily for 12 months

Trial Locations (1)

0000

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
collaborator

Queen Elizabeth Hospital, Hong Kong

OTHER

collaborator

Alice Ho Miu Ling Nethersole Hospital

OTHER

collaborator

Tseung Kwan O Hospital, Hong Kong

OTHER

lead

Chinese University of Hong Kong

OTHER

NCT02537210 - Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative Colitis | Biotech Hunter | Biotech Hunter